Results from the randomized phase 3 DREAMM-8 study of belantamab mafodotin plus pomalidomide and dexamethasone (BPd) vs pomalidomide plus bortezomib and dexamethasone (PVd) in relapsed/refractory ...

Our research team assigns Neutral ratings to strategies they’re not confident will outperform a relevant index, or most peers, over a market cycle on a risk-adjusted basis. The asset allocation ...

This is an updated version of a story first published on March 30, 2025. The original video can be viewed here. This past winter, a series of wildfires fueled by strong winds destroyed more than ...